Buprenorphine hydrochloride and naloxone hydrochloride
Resources
1 resource available
-
Buprenorphine hydrochloride and naloxone hydrochloride
TEXT/HTML
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | ZUBSOLV is a prescription medication containing buprenorphine and naloxone, used to treat opioid dependence by reducing withdrawal symptoms and cravings. It comes as sublingual tablets in various strengths and is a Schedule III controlled substance. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Buprenorphine hydrochloride and naloxone hydrochloride", "mediaType": "text/html", "description": " Access the FDA dataset for Buprenorphine hydrochloride and naloxone hydrochloride — ANDA 204431 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204431" } ] |
| identifier | ANDA204431 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-safety", "fda", "health-care", "prescription-drugs" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Buprenorphine hydrochloride and naloxone hydrochloride |